Principal Investigator
Sara Wester
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220401
Clinical Trial Summary
A Phase 1b, Open-label, Multicenter Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Subcutaneous Dose of TEPEZZA Followed by Multiple Intravenous Doses of TEPEZZA in Participants with Thyroid Eye Disease
Phase
Other
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Jennifer Alvarado
Phone Number
+1 (954) 8177628
Email
jxg1540@miami.edu